BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6141858)

  • 21. Effect of almitrine bismesylate on arterial blood gases and ventilatory drive in patients with severe chronic airflow obstruction and bilateral carotid body resection.
    de Backer W; Bogaert E; Van Maele R; Vermeire P
    Eur J Respir Dis Suppl; 1983; 126():239-42. PubMed ID: 6426993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial effects of almitrine bismesylate on pulmonary gas exchange in COPD.
    Melot C; Naeije R; Hallemans R; Mols P; Lejeune P
    Eur J Respir Dis Suppl; 1983; 126():249-54. PubMed ID: 6586439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement in ventilation-perfusion matching by almitrine in COPD.
    Mélot C; Naeije R; Rothschild T; Mertens P; Mols P; Hallemans R
    Chest; 1983 Mar; 83(3):528-33. PubMed ID: 6130897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A one year double blind follow-up of blood gas tensions and haemodynamics in almitrine bismesylate therapy.
    Préfaut C; Bourgouin-Karaouni D; Ramonatxo M; Michel FB; Macabies J
    Eur Respir J; 1988 Jan; 1(1):41-50. PubMed ID: 2896600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Additive beneficial effects of the prone position, nitric oxide, and almitrine bismesylate on gas exchange and oxygen transport in acute respiratory distress syndrome.
    Jolliet P; Bulpa P; Ritz M; Ricou B; Lopez J; Chevrolet JC
    Crit Care Med; 1997 May; 25(5):786-94. PubMed ID: 9187597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacological properties of almitrine dimesylate. Effects on the ventilation-perfusion ratio].
    Evrard Y
    Presse Med; 1984 Oct; 13(34):2063-9. PubMed ID: 6149533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxygen drive to breathing during halothane anesthesia: effects of almitrine bismesilate.
    Clergue F; Ecoffey C; Derenne JP; Viars P
    Anesthesiology; 1984 Feb; 60(2):125-31. PubMed ID: 6696234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of almitrine and oxygen on arterial blood gases in chronic respiratory insufficiency].
    Magnussen H
    Dtsch Med Wochenschr; 1985 Jan; 110(1):20-3. PubMed ID: 3917396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experimental and clinical bases for the respiratory action of almitrine].
    Lecomte J; Lagneaux D
    Rev Med Liege; 1986 May; 41(10):451-5. PubMed ID: 2874604
    [No Abstract]   [Full Text] [Related]  

  • 30. [Almitrine dimesylate: ventilatory or vascular action].
    Préfaut C; Bourgouin-Karaouni D
    Rev Med Interne; 1985; 6 Spec No():3-7. PubMed ID: 3914681
    [No Abstract]   [Full Text] [Related]  

  • 31. Undetermined utility of almitrine.
    Patz D
    Chest; 1987 May; 91(5):794. PubMed ID: 2882957
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pulmonary hemodynamic monitoring in chronic respiratory insufficiency treated with almitrine bismesilate for 4 months in a double-blind study].
    Bourgouin-Karaouni D; Ramonatxo M; Michel FB; Macabies J; Prefaut C
    Rev Mal Respir; 1984; 1(4):245-50. PubMed ID: 6505362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term effects of almitrine bismesylate on oxygenation during wakefulness and sleep in chronic obstructive pulmonary disease.
    Gothe B; Cherniack NS; Bachand RT; Szalkowski MB; Bianco KA
    Am J Med; 1988 Mar; 84(3 Pt 1):436-44. PubMed ID: 2894764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose almitrine bismesylate in the treatment of hypoxemia due to chronic obstructive pulmonary disease.
    Winkelmann BR; Kullmer TH; Kneissl DG; Trenk D; Kronenberger H
    Chest; 1994 May; 105(5):1383-91. PubMed ID: 8181324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of oral almitrine on the distribution of VA/Q ratio in chronic obstructive lung diseases (author's transl)].
    Castaing Y; Manier G; Varène N; Guénard H
    Bull Eur Physiopathol Respir; 1981; 17(6):917-32. PubMed ID: 7032629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of almitrine, a chemoreceptor stimulator, on nocturnal hypercapnia and pulmonary artery pressure during O2 respiration in chronic obstructive lung disease].
    Rühle KH; Kempf P; Mössinger B; Klein G; Costabel U; Würtemberger G; Matthys H
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():411-4. PubMed ID: 2902613
    [No Abstract]   [Full Text] [Related]  

  • 37. Improvement in ventilation-perfusion relationships by almitrine in patients with chronic obstructive pulmonary disease during mechanical ventilation.
    Castaing Y; Manier G; Guenard H
    Am Rev Respir Dis; 1986 Nov; 134(5):910-6. PubMed ID: 3022628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Almitrine per os in the therapy of chronic obstructive bronchopneumopathies].
    Seignalet C; Préfaut C; Gonzales C; Michel FB
    Rev Fr Mal Respir; 1980; 8(6):627-33. PubMed ID: 7027375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Activity of almitrine bismesylate on pulmonary hemodynamics and on the liberation of prostanoids in the lymph nodes in sheep].
    Douguet D; Dray F; Chollet JM; Zelter M
    Rev Mal Respir; 1985; 2 Suppl 1():S23-7. PubMed ID: 2870543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of the carotid body on gas exchange during exercise.
    Grassi C; Cerveri I; Rampulla C; Tantucci C; Grassi V
    Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():191s-194s. PubMed ID: 3690031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.